{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T17:47:13Z","timestamp":1788284833840,"version":"build-2803163510"},"reference-count":56,"publisher":"Springer Science and Business Media LLC","issue":"4","license":[{"start":{"date-parts":[[2016,6,9]],"date-time":"2016-06-09T00:00:00Z","timestamp":1465430400000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"funder":[{"DOI":"10.13039\/501100003793","name":"Swedish Heart-Lung Foundation","doi-asserted-by":"crossref","id":[{"id":"10.13039\/501100003793","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/501100001862","name":"the Swedish Research Council","doi-asserted-by":"crossref","id":[{"id":"10.13039\/501100001862","id-type":"DOI","asserted-by":"crossref"}]},{"name":"ALF funding (Region Sk\u00e5ne)"},{"name":"Alf funding (Region Sk\u00e5ne)"},{"DOI":"10.13039\/501100006129","name":"King Gustaf V and Queen Victoria\u2019s Foundation of Freemasons","doi-asserted-by":"crossref","id":[{"id":"10.13039\/501100006129","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Thromb Thrombolysis"],"published-print":{"date-parts":[[2016,11]]},"DOI":"10.1007\/s11239-016-1387-7","type":"journal-article","created":{"date-parts":[[2016,6,9]],"date-time":"2016-06-09T09:53:48Z","timestamp":1465466028000},"page":"505-512","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":6,"title":["Venous thromboembolism does not share familial susceptibility with retinal vascular occlusion or glaucoma: a nationwide family study"],"prefix":"10.1007","volume":"42","author":[{"given":"Bengt","family":"Z\u00f6ller","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xinjun","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jan","family":"Sundquist","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kristina","family":"Sundquist","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2016,6,9]]},"reference":[{"key":"1387_CR1","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1097\/IIO.0b013e3181a8db88","volume":"49","author":"JG Haymore","year":"2009","unstructured":"Haymore JG, Mejico LJ (2009) Retinal vascular occlusion syndromes. Int Ophthalmol Clin 49:63\u201379","journal-title":"Int Ophthalmol Clin"},{"key":"1387_CR2","doi-asserted-by":"crossref","first-page":"688","DOI":"10.1038\/eye.2013.25","volume":"27","author":"DD Varma","year":"2013","unstructured":"Varma DD, Cugati S, Lee AW, Chen CS (2013) A review of central retinal artery occlusion: clinical presentation and management. Eye 27:688\u2013697","journal-title":"Eye"},{"key":"1387_CR3","doi-asserted-by":"crossref","first-page":"2135","DOI":"10.1056\/NEJMcp1003934","volume":"363","author":"TY Wong","year":"2010","unstructured":"Wong TY, Scott IU (2010) Clinical practice: retinal-vein occlusion. N Engl J Med 363:2135\u20132144","journal-title":"N Engl J Med"},{"key":"1387_CR4","doi-asserted-by":"crossref","unstructured":"Kolar P (2014) Risk factors for central and branch retinal vein occlusion: a meta-analysis of published clinical data. J Ophthalmol 724780","DOI":"10.1155\/2014\/724780"},{"key":"1387_CR5","doi-asserted-by":"crossref","first-page":"883","DOI":"10.1136\/bjo.85.7.883","volume":"85","author":"M Chak","year":"2001","unstructured":"Chak M, Wallace GR, Graham EM, Stanford MR (2001) Thrombophilia: genetic polymorphisms and their association with retinal vascular occlusive disease. Br J Ophthalmol 85:883\u2013886","journal-title":"Br J Ophthalmol"},{"key":"1387_CR6","doi-asserted-by":"crossref","first-page":"98","DOI":"10.1038\/sj.eye.6700040","volume":"16","author":"CD Fegan","year":"2002","unstructured":"Fegan CD (2002) Central retinal vein occlusion and thrombophilia. Eye 16:98\u2013106","journal-title":"Eye"},{"key":"1387_CR7","doi-asserted-by":"crossref","first-page":"885","DOI":"10.1160\/TH15-02-0141","volume":"114","author":"PM Mannucci","year":"2015","unstructured":"Mannucci PM, Franchini M (2015) Classic thrombophilic gene variants. Thromb Haemost 114:885\u2013889","journal-title":"Thromb Haemost"},{"key":"1387_CR8","doi-asserted-by":"crossref","first-page":"760","DOI":"10.1038\/eye.1995.191","volume":"9","author":"PR Hodgkins","year":"1995","unstructured":"Hodgkins PR, Perry DJ, Sawcer SJ, Keast-Butler J (1995) Factor V and antithrombin gene mutations in patients with idiopathic central retinal vein occlusion. Eye 9:760\u2013762","journal-title":"Eye"},{"key":"1387_CR9","doi-asserted-by":"crossref","first-page":"200","DOI":"10.1136\/bjo.80.3.200","volume":"80","author":"J Larsson","year":"1996","unstructured":"Larsson J, Olafsdottir E, Bauer B (1996) Activated protein C resistance in young adults with central retinal vein occlusion. Br J Ophthalmol 80:200\u2013202","journal-title":"Br J Ophthalmol"},{"key":"1387_CR10","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1136\/bjo.80.3.203","volume":"80","author":"TH Williamson","year":"1996","unstructured":"Williamson TH, Rumley A, Lowe GD (1996) Blood viscosity, coagulation, and activated protein C resistance in central retinal vein occlusion: a population controlled study. Br J Ophthalmol 80:203\u2013208","journal-title":"Br J Ophthalmol"},{"key":"1387_CR11","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1111\/j.1442-9071.1996.tb01581.x","volume":"24","author":"SL Graham","year":"1996","unstructured":"Graham SL, Goldberg I, Murray B, Beaumont P, Chong BH (1996) Activated protein C resistance\u2013low incidence in glaucomatous optic disc haemorrhage and central retinal vein occlusion. Aust N Z J Ophthalmol 24:199\u2013205","journal-title":"Aust N Z J Ophthalmol"},{"key":"1387_CR12","doi-asserted-by":"crossref","first-page":"214","DOI":"10.1055\/s-0038-1655933","volume":"77","author":"T Linna","year":"1997","unstructured":"Linna T, Ylikorkala A, Kontula K, Puska P, Tervo T (1997) Prevalence of factor V Leiden in young adults with retinal vein occlusion. Thromb Haemost 77:214\u2013216","journal-title":"Thromb Haemost"},{"key":"1387_CR13","doi-asserted-by":"crossref","first-page":"832","DOI":"10.1136\/bjo.81.10.832","volume":"81","author":"J Larsson","year":"1997","unstructured":"Larsson J, Sellman A, Bauer B (1997) Activated protein C resistance in patients with central retinal vein occlusion. Br J Ophthalmol 81:832\u2013834","journal-title":"Br J Ophthalmol"},{"key":"1387_CR14","doi-asserted-by":"crossref","first-page":"577","DOI":"10.1001\/archopht.116.5.577","volume":"116","author":"JL Gottlieb","year":"1998","unstructured":"Gottlieb JL, Blice JP, Mestichelli B, Konkle BA, Benson WE (1998) Activated protein C resistance, factor V Leiden, and central retinal vein occlusion in young adults. Arch Ophthalmol 116:577\u2013579","journal-title":"Arch Ophthalmol"},{"key":"1387_CR15","doi-asserted-by":"crossref","first-page":"447","DOI":"10.1097\/00001721-199807000-00009","volume":"9","author":"B Delahousse","year":"1998","unstructured":"Delahousse B, Ars\u00e8ne S, Piquemal R, Iochmann S, Le Lez ML, Pouplard C, Gruel Y (1998) The 20210A allele of the prothrombin gene is not a risk factor for retinal vein occlusion. Blood Coagul Fibrinolysis 9:447\u2013448","journal-title":"Blood Coagul Fibrinolysis"},{"key":"1387_CR16","doi-asserted-by":"crossref","first-page":"308","DOI":"10.1097\/00006982-199807000-00003","volume":"18","author":"AP Ciardella","year":"1998","unstructured":"Ciardella AP, Yannuzzi LA, Freund KB, DiMichele D, Nejat M, De Rosa JT, Daly JR, Sisco L (1998) Factor V Leiden, activated protein C resistance, and retinal vein occlusion. Retina 18:308\u2013315","journal-title":"Retina"},{"key":"1387_CR17","first-page":"702","volume":"80","author":"R Albisinni","year":"1998","unstructured":"Albisinni R, Coppola A, Loffredo M, Cerbone AM, Di Minno G, Greco GM (1998) Retinal vein occlusion and inherited conditions predisposing to thrombophilia. Thromb Haemost 80:702\u2013703","journal-title":"Thromb Haemost"},{"key":"1387_CR18","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1001\/archopht.117.1.43","volume":"117","author":"CJ Glueck","year":"1999","unstructured":"Glueck CJ, Bell H, Vadlamani L, Gupta A, Fontaine RN, Wang P, Stroop D, Gruppo R (1999) Heritable thrombophilia and hypofibrinolysis. Possible causes of retinal vein occlusion. Arch Ophthalmol 117:43\u201349","journal-title":"Arch Ophthalmol"},{"key":"1387_CR19","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1177\/112067219900900107","volume":"9","author":"D G\u00fcven","year":"1999","unstructured":"G\u00fcven D, Sayinalp N, Kalayci D, D\u00fcndar S, Hasiripi H (1999) Risk factors in central retinal vein occlusion and activated protein C resistance. Eur J Ophthalmol 9:43\u201348","journal-title":"Eur J Ophthalmol"},{"key":"1387_CR20","doi-asserted-by":"crossref","first-page":"323","DOI":"10.1016\/S0049-3848(99)00111-5","volume":"96","author":"J Larsson","year":"1999","unstructured":"Larsson J, Hillarp A (1999) The prothrombin gene G20210A mutation and the platelet glycoprotein IIIa polymorphism PlA2 in patients with central retinal vein occlusion. Thromb Res 96:323\u2013327","journal-title":"Thromb Res"},{"key":"1387_CR21","doi-asserted-by":"crossref","first-page":"622","DOI":"10.1034\/j.1600-0420.1999.770602.x","volume":"77","author":"D Kalayci","year":"1999","unstructured":"Kalayci D, G\u00fcrgey A, G\u00fcven D, Parlak H, Hasiripi H (1999) Factor V Leiden and prothrombin 20210 A mutations in patients with central and branch retinal vein occlusion. Acta Ophthalmol Scand 77:622\u2013624","journal-title":"Acta Ophthalmol Scand"},{"key":"1387_CR22","doi-asserted-by":"crossref","first-page":"631","DOI":"10.1034\/j.1600-0420.1999.770605.x","volume":"77","author":"FY Demirci","year":"1999","unstructured":"Demirci FY, G\u00fcney DB, Akar\u00e7ay K, Kir N, Ozbek U, Sirma S, Unaltuna N, Ong\u00f6r E (1999) Prevalence of factor V Leiden in patients with retinal vein occlusion. Acta Ophthalmol Scand 77:631\u2013633","journal-title":"Acta Ophthalmol Scand"},{"key":"1387_CR23","doi-asserted-by":"crossref","first-page":"634","DOI":"10.1034\/j.1600-0420.1999.770606.x","volume":"77","author":"J Larsson","year":"1999","unstructured":"Larsson J, Hillarp A, Olafsdottir E, Bauer B (1999) Activated protein C resistance and anticoagulant proteins in young adults with central retinal vein occlusion. Acta Ophthalmol Scand 77:634\u2013637","journal-title":"Acta Ophthalmol Scand"},{"key":"1387_CR24","doi-asserted-by":"crossref","first-page":"523","DOI":"10.1034\/j.1600-0420.2000.078005523.x","volume":"78","author":"L Hansen","year":"2000","unstructured":"Hansen L, Kristensen HL, Bek T, Ingerslev J (2000) Markers of thrombophilia in retinal vein thrombosis. Acta Ophthalmol Scand 78:523\u2013526","journal-title":"Acta Ophthalmol Scand"},{"key":"1387_CR25","first-page":"195","volume":"15","author":"R Marcucci","year":"2000","unstructured":"Marcucci R, Bertini L, Liotta AA, Rogolino A, Antonucci E, Ilari I, Pepe G, Prisco D (2000) Activated protein C resistance is a risk factor for central retinal vein occlusion. Ann Ital Med Int 15:195\u2013198","journal-title":"Ann Ital Med Int"},{"key":"1387_CR26","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1038\/eye.2000.4","volume":"14","author":"OL Backhouse","year":"2000","unstructured":"Backhouse OL, Parapia L, Mahomed I, Lee D (2000) Familial thrombophilia and retinal vein occlusion. Eye 14:13\u201317","journal-title":"Eye"},{"key":"1387_CR27","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1097\/00006982-200104000-00010","volume":"21","author":"TM Johnson","year":"2001","unstructured":"Johnson TM, El-Defrawy S, Hodge WG, Leonard BC, Kertes PJ, Taylor SAM, Lillicrap DP (2001) Prevalence of factor V Leiden and activated protein C resistance in central retinal vein occlusion. Retina 21:161\u2013166","journal-title":"Retina"},{"key":"1387_CR28","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1159\/000050862","volume":"215","author":"JA Scott","year":"2001","unstructured":"Scott JA, Arnold JJ, Currie JM, Broadfoot C, Davidson M, Kelly KF, Graham A, Kirkpatrick JN, Greaves M (2001) No excess of factor V:Q506 genotype but high prevalence of anticardiolipin antibodies without antiendothelial cell antibodies in retinal vein occlusion in young patients. Ophthalmologica 215:217\u2013221","journal-title":"Ophthalmologica"},{"key":"1387_CR29","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1023\/A:1010639332737","volume":"23","author":"K Greiner","year":"1999","unstructured":"Greiner K, Peetz D, Winkgen A, Prellwitz W, Pfeiffer N, Hafner G (1999) Genetic thrombophilia in patients with retinal vascular occlusion. Int Ophthalmol 23:155\u2013160","journal-title":"Int Ophthalmol"},{"key":"1387_CR30","doi-asserted-by":"crossref","first-page":"511","DOI":"10.1038\/eye.2001.164","volume":"15","author":"O Salomon","year":"2001","unstructured":"Salomon O, Huna-Baron R, Moisseiev J, Rosenberg N, Rubovitz A, Steinberg DM, Davidson J, Sela BA, Seligsohn U (2001) Thrombophilia as a cause for central and branch retinal artery occlusion in patients without an apparent embolic source. Eye 15:511\u2013514","journal-title":"Eye"},{"key":"1387_CR31","doi-asserted-by":"crossref","first-page":"351","DOI":"10.1177\/112067210101100406","volume":"11","author":"S Aras","year":"2001","unstructured":"Aras S, Yilmaz G, Alpas I, Baltaci V, Tayan\u00e7 E, Aydin P (2001) Retinal vein occlusion and factor V Leiden and prothrombin 20210 G: a mutations. Eur J Ophthalmol 11:351\u2013355","journal-title":"Eur J Ophthalmol"},{"key":"1387_CR32","doi-asserted-by":"crossref","first-page":"126","DOI":"10.1002\/ajh.10103","volume":"70","author":"T Bombeli","year":"2002","unstructured":"Bombeli T, Basic A, Fehr J (2002) Prevalence of hereditary thrombophilia in patients with thrombosis in different venous systems. Am J Hematol 70:126\u2013132","journal-title":"Am J Hematol"},{"key":"1387_CR33","doi-asserted-by":"crossref","first-page":"623","DOI":"10.1097\/00001721-200210000-00007","volume":"13","author":"YP Adamczuk","year":"2002","unstructured":"Adamczuk YP, Iglesias Varela ML, Martinuzzo ME, Cerrato GS, Forastiero RR (2002) Central retinal vein occlusion and thrombophilia risk factors. Blood Coagul Fibrinolysis 13:623\u2013626","journal-title":"Blood Coagul Fibrinolysis"},{"key":"1387_CR34","doi-asserted-by":"crossref","first-page":"1048","DOI":"10.1136\/bjo.87.8.1048","volume":"87","author":"Y Chen","year":"2003","unstructured":"Chen Y, Stanford MR, Wallace GR, Vaughan RW, Kondeatis E, Fortune F (2003) Factor V Leiden mutation does not correlate with retinal vascular occlusion in white patients with Beh\u00e7et\u2019s disease. Br J Ophthalmol 87:1048\u20131049","journal-title":"Br J Ophthalmol"},{"key":"1387_CR35","doi-asserted-by":"crossref","first-page":"731","DOI":"10.1038\/sj.eye.6700495","volume":"17","author":"M Weger","year":"2003","unstructured":"Weger M, Renner W, Pinter O, Stanger O, Temmel W, Fellner P, Schmut O, Haas A (2003) Role of factor V Leiden and prothrombin 20210A in patients with retinal artery occlusion. Eye 17:731\u2013734","journal-title":"Eye"},{"key":"1387_CR36","first-page":"299","volume":"154","author":"F Cruciani","year":"2003","unstructured":"Cruciani F, Moramarco A, Curto T, Labate A, Recupero V, Conti L, Gandolfo GM, Balacco Gabrieli C (2003) MTHFR C677T mutation, factor II G20210A mutation and factor V Leiden as risks factor for youth retinal vein occlusion. Clin Ter 154:299\u2013303","journal-title":"Clin Ter"},{"key":"1387_CR37","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1160\/TH04-10-0659","volume":"94","author":"S Ars\u00e8ne","year":"2005","unstructured":"Ars\u00e8ne S, Delahousse B, Regina S, Le Lez ML, Pisella PJ, Gruel Y (2005) Increased prevalence of factor V Leiden in patients with retinal vein occlusion and under 60\u00a0years of age. Thromb Haemost 94:101\u2013106","journal-title":"Thromb Haemost"},{"key":"1387_CR38","doi-asserted-by":"crossref","first-page":"375","DOI":"10.1177\/107602960501100404","volume":"11","author":"CJ Glueck","year":"2005","unstructured":"Glueck CJ, Wang P, Bell H, Rangaraj V, Goldenberg N (2005) Associations of thrombophilia, hypofibrinolysis, and retinal vein occlusion. Clin Appl Thromb Hemost 11:375\u2013389","journal-title":"Clin Appl Thromb Hemost"},{"key":"1387_CR39","doi-asserted-by":"crossref","first-page":"925","DOI":"10.1160\/TH07-11-0658","volume":"99","author":"M Rehak","year":"2008","unstructured":"Rehak M, Rehak J, M\u00fcller M, Faude S, Faude F, Siegemund A, Krcova V, Slavik L, Hasenclever D, Scholz M, Wiedemann P (2008) The prevalence of activated protein C (APC) resistance and factor V Leiden is significantly higher in patients with retinal vein occlusion without general risk factors: case-control study and meta-analysis. Thromb Haemost 99:925\u2013929","journal-title":"Thromb Haemost"},{"key":"1387_CR40","doi-asserted-by":"crossref","first-page":"171","DOI":"10.3129\/i09-273","volume":"45","author":"M Rehak","year":"2010","unstructured":"Rehak M, Krcova V, Slavik L, Fric E, Langova K, Ulehlova J, Rehak J (2010) The role of thrombophilia in patients with retinal vein occlusion and no systemic risk factors. Can J Ophthalmol 45:171\u2013175","journal-title":"Can J Ophthalmol"},{"key":"1387_CR41","doi-asserted-by":"crossref","first-page":"1377","DOI":"10.2147\/OPTH.S34627","volume":"6","author":"CJ Glueck","year":"2012","unstructured":"Glueck CJ, Hutchins RK, Jurantee J, Khan Z, Wang P (2012) Thrombophilia and retinal vascular occlusion. Clin Ophthalmol 6:1377\u20131384","journal-title":"Clin Ophthalmol"},{"key":"1387_CR42","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1016\/j.rce.2013.01.012","volume":"213","author":"JJ Napal Lecumberri","year":"2013","unstructured":"Napal Lecumberri JJ, Sedano Balbas C, Ca\u00f1al Villanueva J, Hern\u00e1ndez Hern\u00e1ndez JL (2013) Thrombophilia and vascular risk factors in retinal vein occlusion. Rev Clin Esp 213:229\u2013234","journal-title":"Rev Clin Esp"},{"key":"1387_CR43","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1159\/000360013","volume":"232","author":"F Risse","year":"2014","unstructured":"Risse F, Frank RD, Weinberger AW (2014) Thrombophilia in patients with retinal vein occlusion: a retrospective analysis. Ophthalmologica 232:46\u201352","journal-title":"Ophthalmologica"},{"key":"1387_CR44","doi-asserted-by":"crossref","first-page":"1367","DOI":"10.1016\/S0140-6736(10)61423-7","volume":"377","author":"HA Quigley","year":"2011","unstructured":"Quigley HA (2011) Glaucoma. Lancet 377:1367\u20131377","journal-title":"Glaucoma. Lancet"},{"key":"1387_CR45","doi-asserted-by":"crossref","first-page":"344","DOI":"10.1159\/000079477","volume":"218","author":"M Nakabayashi","year":"2004","unstructured":"Nakabayashi M (2004) Review of the ischemia hypothesis for ocular hypertension other than congenital glaucoma and closed-angle glaucoma. Ophthalmologica 218:344\u2013349","journal-title":"Ophthalmologica"},{"key":"1387_CR46","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1097\/IJG.0000000000000148","volume":"25","author":"MA Sekeroglu","year":"2016","unstructured":"Sekeroglu MA, Irkec M, Mocan MC, Orhan M (2016) Hereditary thrombophilic factors in glaucoma. J Glaucoma 25:203\u2013207","journal-title":"J Glaucoma"},{"key":"1387_CR47","doi-asserted-by":"crossref","first-page":"890","DOI":"10.1160\/TH15-04-0306","volume":"114","author":"B Z\u00f6ller","year":"2015","unstructured":"Z\u00f6ller B, Li X, Ohlsson H, Ji J, Sundquist J, Sundquist K (2015) Family history of venous thromboembolism as a risk factor and genetic research tool. Thromb Haemost 114:890\u2013900","journal-title":"Thromb Haemost"},{"key":"1387_CR48","doi-asserted-by":"crossref","first-page":"941","DOI":"10.1016\/S0140-6736(05)67322-9","volume":"366","author":"PR Burton","year":"2005","unstructured":"Burton PR et al (2005) Key concepts in genetic epidemiology. Lancet 366:941\u2013951","journal-title":"Lancet"},{"key":"1387_CR49","first-page":"733","volume":"10","author":"N Risch","year":"2001","unstructured":"Risch N (2001) The genetic epidemiology of cancer: interpreting family and twin studies and their implications for molecular genetic approaches. Cancer Epidemiol Biomark Prev 10:733\u2013741","journal-title":"Cancer Epidemiol Biomark Prev"},{"key":"1387_CR50","doi-asserted-by":"crossref","first-page":"102","DOI":"10.33590\/emjcardiol\/10312042","volume":"1","author":"B Z\u00f6ller","year":"2013","unstructured":"Z\u00f6ller B (2013) Nationwide family studies of cardiovascular diseases\u2014clinical and genetic implications of family history. EMJ Cardiol 1:102\u2013113","journal-title":"EMJ Cardiol"},{"key":"1387_CR51","doi-asserted-by":"crossref","first-page":"450","DOI":"10.1186\/1471-2458-11-450","volume":"11","author":"JF Ludvigsson","year":"2011","unstructured":"Ludvigsson JF, Andersson E, Ekbom A, Feychting M, Kim JL, Reuterwall C, Heurgren M, Olausson PO (2011) External review and validation of the Swedish national inpatient register. BMC Public Health 11:450","journal-title":"BMC Public Health"},{"key":"1387_CR52","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1007\/978-3-540-26577-1_5","volume-title":"Handbook of epidemiology","author":"M Rosen","year":"2005","unstructured":"Rosen M, Hakulinen T (2005) Use of disease registers. In: Ahrens W, Pigeot I (eds) Handbook of epidemiology. Springer, Berlin, pp 231\u2013252"},{"key":"1387_CR53","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1007\/978-1-59745-423-0_10","volume":"675","author":"A Ekbom","year":"2011","unstructured":"Ekbom A (2011) The Swedish multi-generation register. Methods Mol Biol 675:215\u2013220","journal-title":"Methods Mol Biol"},{"key":"1387_CR54","doi-asserted-by":"publisher","DOI":"10.1136\/heartjnl-2015-308892","author":"B Z\u00f6ller","year":"2016","unstructured":"Z\u00f6ller B, Li X, Sundquist J, Sundquist K (2016) A nationwide family study of venous thromboembolism and risk of arterial vascular disease. Heart. doi: 10.1136\/heartjnl-2015-308892","journal-title":"Heart"},{"key":"1387_CR55","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1007\/s11239-015-1308-1","volume":"41","author":"W Ageno","year":"2016","unstructured":"Ageno W, Beyer-Westendorf J, Garcia DA, Lazo-Langner A, McBane RD, Paciaroni M (2016) Guidance for the management of venous thrombosis in unusual sites. J Thromb Thrombolysis 41:129\u2013143","journal-title":"J Thromb Thrombolysis"},{"key":"1387_CR56","doi-asserted-by":"crossref","first-page":"558","DOI":"10.1111\/j.1538-7836.2007.02857.x","volume":"6","author":"A Rosengren","year":"2008","unstructured":"Rosengren A, Fred\u00e9n M, Hansson P-O, Wilhelmsen L, Wedel H, Eriksson H (2008) Psychosocial factors and venous thromboembolism: a long-term follow-up study of Swedish men. J Thromb Haemost 6:558\u2013564","journal-title":"J Thromb Haemost"}],"container-title":["Journal of Thrombosis and Thrombolysis"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s11239-016-1387-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s11239-016-1387-7\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s11239-016-1387-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,8,18]],"date-time":"2023-08-18T20:35:16Z","timestamp":1692390916000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s11239-016-1387-7"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,6,9]]},"references-count":56,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2016,11]]}},"alternative-id":["1387"],"URL":"https:\/\/doi.org\/10.1007\/s11239-016-1387-7","relation":{},"ISSN":["0929-5305","1573-742X"],"issn-type":[{"value":"0929-5305","type":"print"},{"value":"1573-742X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2016,6,9]]}}}